Transplant and Oncology Infectious Disease Research
Dr. Lindsey Baden
Led by Dr. Lindsey Baden, research by the Transplantation and Oncology Infectious Diseases group focuses on the development of novel diagnostics and therapeutics for fungal and viral diseases that affect transplant and cancer patient populations disproportionately.
Dr. Francisco Marty
Dr. Marty is a leader in the conduct of clinical trials of novel agents for the prevention and treatment of cytomegalovirus and respiratory viruses and continues his work on the clinical epidemiology of different infectious diseases affecting transplant and oncology patients.
Dr. Sophia Koo
Dr. Sophia Koo, in collaboration with colleagues at the Draper Labs, is leading the development of non-invasive breath-based diagnosis of pulmonary fungal infections based on exhaled volatile fungal metabolites.
Dr. Sarah Hammond
Dr. Hammond is leading different efforts to understand and mitigate the risk of hepatitis B virus disease in patients undergoing cancer chemotherapy and transplant and is now the group’s leader of multicenter trials of antifungal trials of invasive fungal disease in immunocompromised hosts.
Dr. Nicolas Issa
Dr. Issa is pursuing in-depth research of novel investigational and currently approved vaccines in different immunocompromised populations.